|
Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline Clinical research trials and Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline. Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline clinical trial. Test subjects typically receive the most effective healthcare possible for their Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "F" Clinical Trials Conditions > Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline  Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline
Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline
For Condition: Smoking
Status: Recruiting
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service
Synopsis: The primary objective of this study is to assess the effectiveness of an intervention for increasing the rate of tobacco dependence treatment in a population of smokers identified through the VA Pharmacy Benefits Management database. Secondary objectives of this study include (1) assessing the effect of the intervention on smoking cessation rates, and (2) developing options for overcoming potential barriers to broad implementation of the strategies.
Details: The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation Clinical Practice Guideline provides specific recommendations for treating tobacco dependence. Despite their strong evidence base, however, these recommendations have not been fully integrated into clinical practice within the VHA. Recent data suggest that logistical difficulties associated with identifying and linking smokers with appropriate treatments may explain why the PHS Smoking Cessation Guideline has not been more broadly implemented. The effectiveness of the intervention will be evaluated using a multi-center, randomized, controlled trial. Veterans receiving a prescription for transdermal nicotine, nicotine gum, or bupropion for smoking cessation in the past year at one of the participating VHA facilities (as determined from Pharmacy Benefits Management records) will be eligible for the study. A total of 2,400 eligible veterans selected from eight test sites will be randomly assigned to one of two groups: (1) patient phone call and tailored, computerized prompt to providers (intervention), or (2) usual care (control). The primary outcome is the proportion of patients receiving pharmacological or other smoking cessation treatment in the six month follow-up period, as assessed from VA pharmacy and outpatient data files. All patients will be recruited to a brief phone interview six months post-intervention to gather secondary outcome measure data related to smoking status, quit history, and use of smoking cessation assistance.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Single Blind, Active Control, Single Group Assignment
Minimum Age/Maximum Age: 19 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Subjects must have received a prescription for a smoking cessation medication in 2002
Total Enrollment: 2400
Location and Contact Information:
VA Medical Center *Recruiting*
Minneapolis, Minnesota, 55417
United States
Recruiting Melissa Partin 612-725-2000
Additional Information:
Study ID Numbers: TRX 01-080;
Study Start Date: October 2001
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057070
Other Smoking Studies:
1. Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
2. Bupropion as a Smoking Cessation Aid in Alcoholics
3. A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline
4. Ultrasound and motivational enhancement for prenatal smoking cessation
5. Naltrexone and Patch for Smokers
Related Studies:
Other Smoking Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials
Facilitating Implementation of the U.S. Public Health Service Smoking Cessation Guideline
|
|
|
|
|
|
|
|
